41![](/pdf-icon.png) | Add to Reading ListSource URL: www.actavis.com.mtLanguage: English - Date: 2015-05-05 21:30:03
|
---|
42![This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 fo This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 fo](https://www.pdfsearch.io/img/fc99ac922e6b02911e8684cf85f831b9.jpg) | Add to Reading ListSource URL: www.actavis.com.mtLanguage: English - Date: 2015-05-06 15:34:46
|
---|
43![Report from the meeting held on 18 February 2002 General issues A medicinal product used as comparison for bioequivalence study With reference to Chapter 1 of the NTA it was confirmed that a medicinal product used as com Report from the meeting held on 18 February 2002 General issues A medicinal product used as comparison for bioequivalence study With reference to Chapter 1 of the NTA it was confirmed that a medicinal product used as com](https://www.pdfsearch.io/img/0ec425909c4663aa41f743bc4e05340c.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2007-01-31 06:06:11
|
---|
44![](/pdf-icon.png) | Add to Reading ListSource URL: www.actavis.com.mtLanguage: English - Date: 2015-05-06 04:03:49
|
---|
45![SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Luvinsta SR 80 mg prolonged-release tablets SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Luvinsta SR 80 mg prolonged-release tablets](https://www.pdfsearch.io/img/fb66150f677f68bf8b39099af21b4bdf.jpg) | Add to Reading ListSource URL: www.actavis.com.mtLanguage: English - Date: 2015-05-06 03:13:17
|
---|
46![1. NAME OF THE MEDICINAL PRODUCT Siprox 250 mg film-coated tablets Siprox 500 mg film-coated tablets 1. NAME OF THE MEDICINAL PRODUCT Siprox 250 mg film-coated tablets Siprox 500 mg film-coated tablets](https://www.pdfsearch.io/img/cd24407bf559b4884dd6ca0858fa9b7f.jpg) | Add to Reading ListSource URL: www.actavis.com.mtLanguage: English - Date: 2015-05-06 06:17:25
|
---|
47![Reflection paper on Non-clinical studies for Generic Nanoparticular Iron Medicinal Product Applications Reflection paper on Non-clinical studies for Generic Nanoparticular Iron Medicinal Product Applications](https://www.pdfsearch.io/img/e6e333d53e10a34c00569f7befbf2c1c.jpg) | Add to Reading ListSource URL: www.ema.europa.euLanguage: English - Date: 2013-07-21 06:13:53
|
---|
48![Microsoft Worddoc Microsoft Worddoc](https://www.pdfsearch.io/img/a5d634d50f69af3ecb051e923ba8cd19.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2007-02-25 20:37:12
|
---|
49![1. NAME OF THE MEDICINAL PRODUCT Luvinsta 20 mg capsules, hard Luvinsta 40 mg capsules, hard 1. NAME OF THE MEDICINAL PRODUCT Luvinsta 20 mg capsules, hard Luvinsta 40 mg capsules, hard](https://www.pdfsearch.io/img/fcae57fb94bfa532f6cb5278edebe0ea.jpg) | Add to Reading ListSource URL: www.actavis.com.mtLanguage: English - Date: 2015-05-06 15:02:06
|
---|
50![CleanWell Personal Care Product Ingredients TM We believe in ingredient transparency. That means you’ll find our ingredients listed on the label of each of our products as well as on our website. D CleanWell Personal Care Product Ingredients TM We believe in ingredient transparency. That means you’ll find our ingredients listed on the label of each of our products as well as on our website. D](https://www.pdfsearch.io/img/63f645d2a000f45c68c887de9fb50da6.jpg) | Add to Reading ListSource URL: www.cleanwelltoday.comLanguage: English - Date: 2014-06-16 14:18:26
|
---|